Cibc World Markets Corp Alnylam Pharmaceuticals, Inc. Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 5,868 shares of ALNY stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,868
Previous 5,810
1.0%
Holding current value
$1.81 Million
Previous $1.37 Million
15.87%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ALNY
# of Institutions
720Shares Held
111MCall Options Held
978KPut Options Held
881K-
Capital World Investors Los Angeles, CA16.7MShares$5.16 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.02 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.94 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.2 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.36 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $37.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...